Skip to main content

Advertisement

Table 2 Clinical characteristics and fasting serum N-terminal pro-B-type natriuretic peptide levels of 84 elderly persons

From: N-terminal pro-B-type natriuretic peptide level inversely associates with metabolic syndrome in elderly persons

Characteristic Number (%) NT-proBNP (pg/ml) P value
Gender Male 28 (33.3) 173.50 ± 227.45 0.284
Female 56 (66.7) 290.14 ± 302.88
Diabetes No 54 (64.3) 218.80 ± 275.99 0.636
Yes 30 (35.7) 269.30 ± 289.92
Hypertension No 16 (19.1) 336.25 ± 370.62 0.223
Yes 68 (80.9) 231.26 ± 260.74
Metabolic syndrome No 46 (54.8) 384.87 ± 342.22 0.001*
Yes 38 (45.2) 89.53 ± 55.88
ACE inhibitor No 68 (80.9) 236.53 ± 281.99 0.748
Yes 16 (19.1) 313.88 ± 296.03
ARB No 40 (47.6) 306.30 ± 315.87 0.251
Yes 44 (52.4) 201.23 ± 245.44
β-blocker No 46 (54.8) 262.09 ± 310.44 0.622
Yes 38 (45.2) 238.16 ± 252.79
CCB No 38 (45.2) 326.26 ± 325.47 0.100
Yes 46 (54.8) 189.30 ± 231.05
Statin No 64 (76.2) 276.50 ± 306.19 0.506
Yes 20 (23.8) 170.50 ± 177.76
Fibrate No 74 (88.1) 264.46 ± 296.72 0.938
Yes 10 (11.9) 168.40 ± 130.17
Sulfonylurea No 76 (90.5) 265.50 ± 293.33 0.780
Yes 8 (9.5) 116.00 ± 62.79
Metformin No 66 (78.6) 249.15 ± 268.06 0.690
Yes 18 (21.4) 259.00 ± 349.32
  1. Data are expressed as means ± standard deviations.
  2. *P < 0.05 was considered statistically significant after Mann–Whitney U test.
  3. NT-pro-BNP, N-terminal pro-B-type natriuretic peptide; ARB, angiotensin-receptor blocker; ACE, angiotensin-converting enzyme; CCB, calcium-channel blocker.